… core–shell nanoparticles were developed for the precisely targeted therapy of UC. Core–shell …
pH-responsive release of core–shell nanoparticles fabricated via the skillful application of …

… -shell nanoparticles (ES 1 CS 5 SA 5 @5-ASANCs) were prepared used for colon targeted
therapy of ulcerative colitis (… The distinct core-shell structure of nanoparticles can be observed …

… oral core–shell nanoparticles composed of curcumin … shell for inflammation-targeted
alleviation of ulcerative colitis (UC). The release rate of curcumin from the core–shell nanoparticles …

… PCL-AC shell, final … nanoparticles function as desirable and worthy carriers to achieve
superior therapeutic benefits of naïve drugs for the therapy of acute experimental ulcerative colitis …

… a core–shell nanoparticle for targeted delivery of GA to inhibit ulcerative colitis. As indicated
from the physical and chemical properties exhibited by the nanoparticles, the nanoparticles …

… The oral colon-targeting drug delivery vehicle is vital for the efficient application of curcumin
(Cur) in ulcerative colitis (UC) treatment because of its lipophilicity and instability in the …

… Ulcerative colitis (UC) is an inflammatory bowel disease with a high risk of developing
colon cancer. The pathological features of UC include a disrupted epithelial barrier and …

… to play protective effects on ulcerative colitis (UC), its … into the core–shell zein-based
nanoparticles with chondroitin … of the combination of hybrid nanoparticles-in-microparticles, …

… successfully developed a new type of colitis tissue-accumulating porous nanoparticle (NP)
with surface functionalization of pluronic F127 (PF127) for ulcerative colitis (UC) therapy. The …

… Ulcerative colitis (UC) with complex pathogenesis is a chronic inflammatory bowel disease
… shell layer, and chitosan was used as the external shell layer. The Core-shell nanoparticles, …